Skip to main content

Articles

Page 3 of 16

  1. There is limited evidence-informed guidance on TISP processes for countries where health technology assessment (HTA) is in a nascent phase. We aimed to explore the range of topic identification, selection and ...

    Authors: Julia Bidonde, Vigdis Lauvrak, Aparna Ananthakrishnan, Pritaporn Kingkaew and Elizabeth F. Peacocke
    Citation: Cost Effectiveness and Resource Allocation 2024 22:12
    Content type: Research Published on:

  2. The treatment of hepatitis C has entered the pan-genotypic era, but the effectiveness is not good for the genotype 3b patients who have a large proportion in China. The guidelines for hepatitis C recommend the...

    Authors: Yusi Tu, Xiangyan Tang, Dachuang Zhou, Hanqiao Shao, Leyi Liang and Wenxi Tang
    Citation: Cost Effectiveness and Resource Allocation 2024 22:11
    Content type: Research Published on:

  3. Preference elicitation is widely used within health economic evaluations to inform coverage decisions. However, coverage decisions involve questions of social justice and it is unclear what role empirical evid...

    Authors: Wolf Rogowski and Jürgen John
    Citation: Cost Effectiveness and Resource Allocation 2024 22:10
    Content type: Review Published on:

  5. Combined serplulimab and chemotherapy demonstrated improved clinical survival outcomes in patients with advanced esophageal squamous cell carcinoma (ESCC) and PD-L1 combined positive scores (CPS) ≥ 1. The pres...

    Authors: Jiahui Li, Chaoqun Xu and Suyun Yuan
    Citation: Cost Effectiveness and Resource Allocation 2024 22:8
    Content type: Research Published on:

  7. Programmed cell death protein 1 (PD-1) monoclonal antibody, pembrolizumab, is a promising drug for platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (NPC). We aimed to assess the cost-effectiv...

    Authors: Jing Nie, Huina Wu, Qian Wu, Lihui Liu, Ke Tang, Shuo Wang and Jiyong Wu
    Citation: Cost Effectiveness and Resource Allocation 2024 22:6
    Content type: Research Published on:

  9. Add-on therapy with tiotropium was cost-effective when added to usual care in patients who remain uncontrolled despite treatment with medium or high-dose ICS/LABA in a middle-income country.

    Authors: Jefferson Antonio Buendía and Diana Guerrero Patiño
    Citation: Cost Effectiveness and Resource Allocation 2024 22:4
    Content type: Research Published on:

  10. Human communities suffered a vast socioeconomic burden in dealing with the pandemic of coronavirus disease 2019 (COVID-19) globally. Real-word data about these burdens can inform governments about evidence-bas...

    Authors: Majid Nakhaee, Masoud Khandehroo and Reza Esmaeili
    Citation: Cost Effectiveness and Resource Allocation 2024 22:3
    Content type: Review Published on:

  11. Access to convenient quality healthcare at all times is considered a basic human right; however, many countries are still striving to achieve this goal for their populations. The persistent rise in healthcare ...

    Authors: Mohammed Khaled Al-Hanawi and Naseem Al Rahahleh
    Citation: Cost Effectiveness and Resource Allocation 2024 22:2
    Content type: Research Published on:

  12. Maternal and neonatal mortality in low- and middle-income countries is frequently caused by inadequate management of obstetric and neonatal complications and a shortage of skilled health workers. The availabil...

    Authors: Chakib Boukhalfa, Brahim Ouakhzan, Hanane Masbah, Leila Acharai and Saad Zbiri
    Citation: Cost Effectiveness and Resource Allocation 2024 22:1
    Content type: Research Published on:

  13. In China, the healthcare financing structure involves multiple parties, including the government, society and individuals. Medicare Fund is an important way for the Government and society to reduce the burden ...

    Authors: Wenqing Wu, Shujie Long, Arcadio A. Cerda, Leidy Y. Garcia and Mihajlo Jakovljevic
    Citation: Cost Effectiveness and Resource Allocation 2023 21:97
    Content type: Review Published on:

  14. The value of a life is regularly monetised by government departments for informing resource allocation. Guidance documents indicate how economic evaluation should be conducted, often specifying precise values ...

    Authors: Patricia Cubi-Molla, David Mott, Nadine Henderson, Bernarda Zamora, Mendel Grobler and Martina Garau
    Citation: Cost Effectiveness and Resource Allocation 2023 21:96
    Content type: Research Published on:

  15. Psoriasis, an immune-mediated chronic inflammatory disease primarily affecting skin and joints, has varying prevalence rates globally. It manifests in five types, with chronic plaque psoriasis being the most c...

    Authors: Yazed AlRuthia, Almaha H. Alfakhri, Ibtisam Alharbi, Fadi Ali Alghamdi, Miteb A. Alanazi, Abdullah Abdulrahman Alrabiah, Anwar Abdulrazzag Alsouan, Abdulrahman Abdullah Alshaikh and Majed Ali Almasaoud
    Citation: Cost Effectiveness and Resource Allocation 2023 21:95
    Content type: Research Published on:

  16. Although the treatment for end-stage renal disease (ESRD) under Nigeria’s National Health Insurance Authority is haemodialysis (HD), the cost of managing ESRD is understudied in Nigeria. Therefore, this study ...

    Authors: Yakubu Adole Agada-Amade, Daniel Chukwuemeka Ogbuabor, Ejemai Eboreime and Obinna Emmanuel Onwujekwe
    Citation: Cost Effectiveness and Resource Allocation 2023 21:94
    Content type: Research Published on:

  17. According to the Chinese guidelines for lipid management (2023), evolocumab in combination with statins was recommended as secondary prevention of cardiovascular disease. However, because of the variation in t...

    Authors: Yuansheng Wan, Jinyu Liu, Xiaolian Zhan, Yu Zhang and Ruxu You
    Citation: Cost Effectiveness and Resource Allocation 2023 21:93
    Content type: Research Published on:

  19. The aim of this article is to evaluate the cost-effectiveness of abemaciclib plus endocrine therapy (ABE + ET) vs. ET as adjuvant treatment for high-risk hormone receptor-positive and human epidermal growth fa...

    Authors: Qiran Wei, YuTing Xu, Wei Liu and Xin Guan
    Citation: Cost Effectiveness and Resource Allocation 2023 21:91
    Content type: Research Published on:

  21. This study investigates Iranian men’s willingness to pay (WTP) for prostate cancer (PCa) screening and influencing factor, along with the impact of information.

    Authors: Hiro Farabi, Najmeh Moradi, Aziz Ahmadzadeh, Seyed Mohammad Kazem Agamir, Abdolreza Mohammadi and Aziz Rezapour
    Citation: Cost Effectiveness and Resource Allocation 2023 21:89
    Content type: Research Published on:

  22. To investigate the cost-effectiveness of using Implant Movement Analysis (IMA) to follow up suspected aseptic loosening when the diagnosis after an initial X-ray is not conclusive, compared with a diagnostic p...

    Authors: Davide Lovera, Olof Sandberg, Maziar Mohaddes and Hanna Gyllensten
    Citation: Cost Effectiveness and Resource Allocation 2023 21:88
    Content type: Research Published on:

  23. Demonstrating safety and efficacy of new medical treatments requires clinical trials but clinical trials are costly and may not provide value proportionate to their costs. As most health systems have limited r...

    Authors: Piers Gillett, Robert K Mahar, Nancy R Tran, Mark Rosenthal and Maarten IJzerman
    Citation: Cost Effectiveness and Resource Allocation 2023 21:87
    Content type: Research Published on:

  24. Breast cancer represents the most prevalent cancer among Swedish women. Although considerable research has investigated the cost-effectiveness of emerging innovative medical treatments for breast cancer, studi...

    Authors: Phu Duy Pham, Muchandifunga Trust Muchadeyi and Lars Lindholm
    Citation: Cost Effectiveness and Resource Allocation 2023 21:86
    Content type: Research Published on:

  25. Management of COVID-19 patients with mild and moderate symptoms could be isolated at home isolation (HI), community isolation (CI) or hospitel. However, it was still unclear which strategy was more cost-effect...

    Authors: Unyaporn Suthutvoravut, Patratorn Kunakorntham, Anchisatha Semayai, Amarit Tansawet, Oraluck Pattanaprateep, Pongsathorn Piebpien, Pawin Numthavaj, Ammarin Thakkinstian and Pongsakorn Atiksawedparit
    Citation: Cost Effectiveness and Resource Allocation 2023 21:85
    Content type: Research Published on:

  26. Prostate cancer is the second most common cancer in males worldwide and the third most common among Iran’s male population. However, there is a lack of evidence regarding its direct and indirect costs in low a...

    Authors: Farbod Alinezhad, Farhad Khalili, Hossein Zare, Chunling Lu, Zahra Mahmoudi and Mahmood Yousefi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:84
    Content type: Research Published on:

  27. Artificial Intelligence (AI) represents a significant advancement in technology, and it is crucial for policymakers to incorporate AI thinking into policies and to fully explore, analyze and utilize massive da...

    Authors: Maryam Ramezani, Amirhossein Takian, Ahad Bakhtiari, Hamid R. Rabiee, Ali Akbar Fazaeli and Saharnaz Sazgarnejad
    Citation: Cost Effectiveness and Resource Allocation 2023 21:83
    Content type: Review Published on:

  28. In recent years, numerous guidelines and expert consensus have recommended the inclusion of digital technologies and products in cardiac rehabilitation. Digital therapeutics (DTx) is an evidence-based medicine...

    Authors: Tianyi Liu, Yiyang Zhan, Silei Chen, Wenhong Zhang and Jian Jia
    Citation: Cost Effectiveness and Resource Allocation 2023 21:82
    Content type: Research Published on:

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2024 22:16

  29. Chronic Kidney Disease (CKD) patients often require long-term care, and while Hemodialysis (HD) is the standard treatment, Comprehensive Conservative Care (CCC) is gaining popularity as an alternative. Economi...

    Authors: Telma Zahirian Moghadam, Jane Powell, Afshan Sharghi and Hamed Zandian
    Citation: Cost Effectiveness and Resource Allocation 2023 21:81
    Content type: Research Published on:

  30. Monetizing health has sparked controversy and has implications for pricing strategies of emerging health technologies. Medical insurance payers typically set up thresholds for quality-adjusted life years (QALY...

    Authors: Qian Peng, Yue Yin, Min Liang, Mingye Zhao, Taihang Shao, Yaqian Tang, Zhiqing Mei, Hao Li and Wenxi Tang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:80
    Content type: Research Published on:

  31. In recent years, international academics recognized that quality-adjusted life-years (QALYs) may not always fully capture the benefits produced by an intervention, and considered incorporating additional eleme...

    Authors: Lihua Sun, Shiqi Li and Xiaochen Peng
    Citation: Cost Effectiveness and Resource Allocation 2023 21:79
    Content type: Comment Published on:

  32. Dealing with randomness is a crucial aspect that cost-effectiveness analysis (CEA) tools need to address, but existing stochastic CEA tools have rarely examined risk and return from the perspective of populati...

    Authors: Ermo Chen
    Citation: Cost Effectiveness and Resource Allocation 2023 21:78
    Content type: Methodology Published on:

  33. Hip fractures are a common and costly health problem, resulting in significant morbidity and mortality, as well as high costs for healthcare systems, especially for the elderly. Implementing surgical preventiv...

    Authors: Momin S. Alnemer, Konstantin E. Kotliar, Valentin Neuhaus, Hans-Christoph Pape and Bernhard D. Ciritsis
    Citation: Cost Effectiveness and Resource Allocation 2023 21:77
    Content type: Research Published on:

  34. The increasing global prevalence of atrial fibrillation (AF) has led to a growing demand for stroke prevention strategies, resulting in higher healthcare costs. High-quality economic evaluations of stroke prev...

    Authors: Sumudu A. Hewage, Rini Noviyani, David Brain, Pakhi Sharma, William Parsonage, Steven M. McPhail, Adrian Barnett and Sanjeewa Kularatna
    Citation: Cost Effectiveness and Resource Allocation 2023 21:76
    Content type: Research Published on:

  35. Countries around the world are increasingly rethinking the design of their health benefit package to achieve universal health coverage. Countries can periodically revise their packages on the basis of sectoral...

    Authors: Rob Baltussen, Gavin Surgey, Anna Vassall, Ole F. Norheim, Kalipso Chalkidou, Sameen Siddiqi, Mojtaba Nouhi, Sitaporn Youngkong, Maarten Jansen, Leon Bijlmakers and Wija Oortwijn
    Citation: Cost Effectiveness and Resource Allocation 2023 21:75
    Content type: Research Published on:

  36. Authors: Richard Niehaus, Alisa Schleicher, Ammann Elias, Philipp Kriechling, Christopher G. Lenz, Michael Masanneck, Sandro Hodel and Karim Eid
    Citation: Cost Effectiveness and Resource Allocation 2023 21:74
    Content type: Correction Published on:

    The original article was published in Cost Effectiveness and Resource Allocation 2023 21:63

  37. Because of a change of government, the Colombian Ministry of Health and Social Protection is in the process of presenting a structural reform for the General System of Social Security in Health (GSSSH), in ord...

    Authors: Oscar Espinosa, Jhonathan Rodríguez, B. Piedad Urdinola, Pedro Luis Do Nascimento Silva, Alejandra Sánchez, Martha-Liliana Arias, Emiliano A. Valdez, Terence Cheng and Sara-Ellison Fisher
    Citation: Cost Effectiveness and Resource Allocation 2023 21:73
    Content type: Research Published on:

  40. The Covid-19 pandemic has had serious medical, administrative and financial effects on the health system and hospitals around the world. In Türkiye, compared to 2019 realizations, in 2020 and 2021 respectively...

    Authors: Seher Nur Sülkü, Alper Mortaş and Aziz Küçük
    Citation: Cost Effectiveness and Resource Allocation 2023 21:70
    Content type: Research Published on:

  41. The global increase in mean body mass index has resulted in a substantial increase of non-communicable diseases (NCDs), including in many low- and middle-income countries such as Kenya. This paper assesses fou...

    Authors: Mary Njeri Wanjau, Lucy W. Kivuti-Bitok, Leopold N. Aminde and J. Lennert Veerman
    Citation: Cost Effectiveness and Resource Allocation 2023 21:69
    Content type: Research Published on:

  42. Tuberculosis (TB) is a communicable disease that is a major cause of death and one of the leading causes of death worldwide. Currently, there is no analyzed data to examine the financial profile of TB by count...

    Authors: Maryam Meskini, Nahid Madadi, Kamal Ahmadi, Farzam Vaziri, Abolfazl Fateh and Seyed Davar Siadat
    Citation: Cost Effectiveness and Resource Allocation 2023 21:68
    Content type: Research Published on:

  43. The use of peripherally inserted central catheters and midline catheters is growing due to their potential benefits. These devices can increase patient safety and satisfaction while reducing the use of resourc...

    Authors: Laura Ricou Ríos, Candela Esposito Català, Arnau Pons Calsapeu, Cristina Adroher Mas, Isabel Andrés Martínez, Isaac Nuño Ruiz, Mònica Castellà Creus, Laia Castellà Fàbregas, Maria José García Quesada, Oriol Estrada Cuxart, Jordi Ara del Rey and Francesc López Seguí
    Citation: Cost Effectiveness and Resource Allocation 2023 21:67
    Content type: Research Published on:

  44. In an effort to minimize positive margins and subsequent re-excision after breast conserving surgery (BCS), many providers and facilities have implemented either a Full Cavity Shave (FCS) approach or adding th...

    Authors: Richard Gilmore, Jennifer Chen, Robert Dembinski, Yannis Reissis, David Milek, Lisa Cadena and Mehran Habibi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:66
    Content type: Methodology Published on:

  45. The aim of the study was to evaluate the cost-effectiveness of nivolumab plus chemotherapy as first-line treatment for patients with advanced gastric, gastroesophageal junction (GEJ), or esophageal adenocarcin...

    Authors: Peng-Fei Zhang, Xuan-Qiong Shi and Qiu Li
    Citation: Cost Effectiveness and Resource Allocation 2023 21:65
    Content type: Research Published on:

  46. To evaluate the cost-effectiveness ratio and economic impact of the Rapid Antigen Test (TR-Ag) to replace RT-PCR for the detection of the new Coronavirus in the Unified Health System (SUS).

    Authors: Vinicius Queiroz Miranda Cedro, Stéfany de Lima Gomes, Ana Clara Correa Duarte Simões, Tatiana do Valle Lovato Sverzut, Keila Cristina Xavier Bertti, Marcelo Tadeu Tristão, Yuri Wanderley Cavalcanti, João Victor Frazão Câmara and Antonio Carlos Pereira
    Citation: Cost Effectiveness and Resource Allocation 2023 21:64
    Content type: Research Published on:

  47. Acromioclavicular joint dislocations (ACD) are one of the most common shoulder injuries. There is no consensus in how to treat higher graded ACD ≥ Rockwood grade III. This study compares operative versus conse...

    Authors: Richard Niehaus, Alisa Schleicher, Elias Ammann, Philipp Kriechling, Christopher G. Lenz, Michael Masanneck, Sandro Hodel and Karim Eid
    Citation: Cost Effectiveness and Resource Allocation 2023 21:63
    Content type: Research Published on:

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:74

  48. Cost-effectiveness analysis (CEA) is a standard tool for evaluating health programs and informing decisions about resource allocation and prioritization. Most CEAs evaluating health interventions in low- and m...

    Authors: Joseph Corlis, Jinyi Zhu, Hélder Macul, Orrin Tiberi, Makini A. S. Boothe and Stephen C. Resch
    Citation: Cost Effectiveness and Resource Allocation 2023 21:62
    Content type: Methodology Published on:

  49. In December 2022, the Taiwan National Health Insurance Administration (NHIA) announced the reimbursement of three dosages of pemigatinib 4.5 mg, 9 mg, and 13.5 mg for treating advanced intrahepatic cholangioca...

    Authors: Zi-Rong Chen, Chen-Han Chueh, Nai-Jung Chiang and Yi-Wen Tsai
    Citation: Cost Effectiveness and Resource Allocation 2023 21:61
    Content type: Research Published on:

  50. To date, there have been no published studies evaluating the cost-effectiveness of robot-assisted gait training (RAGT) in adolescent and adult patients with cerebral palsy (CP). The study´s aim was to analyse ...

    Authors: Stanislava Klobucká, Robert Klobucký, Katarína Valovičová, Pavol Šiarnik and Branislav Kollár
    Citation: Cost Effectiveness and Resource Allocation 2023 21:60
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.7
    5-year Journal Impact Factor: 2.1
    Source Normalized Impact per Paper (SNIP): 0.749
    SCImago Journal Rank (SJR): 0.610

    Speed 2024
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 168

    Usage 2024
    Downloads: 550,922
    Altmetric mentions: 312

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us